Total visits last 3 months
| Last Month Change | 6.99% | 17.93% |
| Avg Visit Duration | 00:01:05 | 00:00:26 |
| Pages per Visit | 1.72 | 1.73 |
| Bounce Rate | 42.73% | 42.93% |
| Compare any site with a free trial | ||
ferringusa.com VS. 
nephronpharm.com
ferringusa.com
Patients with high-risk, non-muscle invasive bladder cancer now have greater access to the first and only FDA-approved intravesical gene therapy With full supply of ADSTILADRIN ahead of schedule, Ferring ends the temporary ADSTILADRIN Early Experience Program Enrollment in ABLE-41 U.S. Real-World Evidence Study is ongoing Parsippany, NJ – January 16, 2024 – Ferring Pharmaceuticals today announced that ADSTILADRIN® (nadofaragene firadenovec-vncg) …
Global Rank
#1,976,309
nephronpharm.com
We produce affordable, high-quality inhalation solutions and suspension products that treat respiratory conditions. We value our customers in South Carolina.
Global Rank
#2,138,996
ferringusa.com vs. nephronpharm.com Ranking Comparison
Compare ferringusa.com global ranking trend in the past 3 months vs. nephronpharm.com, or dive deeper into ferringusa.com ranking in its category or country measured against nephronpharm.com
Country Rank Last Month
ferringusa.com
#644,146nephronpharm.com
#674,192
Traffic and Engagement
nephronpharm.com had more total visits compared to ferringusa.com in May 2026.
Traffic share by country: ferringusa.com vs. nephronpharm.com
ferringusa.com vs nephronpharm.com country based traffic analysis shows nephronpharm.com gets the most traffic from United States, while nephronpharm.com gets a smaller share
Top Countries
ferringusa.com
43.3%
nephronpharm.com
56.7%
United States